@ttzirtis
You are often reasonable - what are your thoughts on the LTI not having production vesting requirements and the termination payment approvals?
I don't think the board would position to remove any of the existing directors subject to remuneration approvals, so I can only see it as t/o preparation.
At a time when he has full insight into the DFS and we have none I am worried he is seeing roadblocks to production we can't.
I guess he may have received informal EOIs in the form of, "when is DFS ready" from funds or trade players and maybe expects a potential T/O - if worried about a T/O keep the termination benefits and change that $1 tranche to a production target.
In my head that makes us know Board is aligned to the long term, and understand if the opportunity to grow this thing is taken away by a T/O they should be remunerated for spending the time they have on developing this company. So a win win that we can break bread.
- Forums
- ASX - By Stock
- LRV
- Ann: Notice of Annual General Meeting/Proxy Form
LRV
larvotto resources limited
Add to My Watchlist
3.25%
!
63.5¢

Ann: Notice of Annual General Meeting/Proxy Form, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
63.5¢ |
Change
0.020(3.25%) |
Mkt cap ! $261.8M |
Open | High | Low | Value | Volume |
66.5¢ | 67.5¢ | 62.0¢ | $2.341M | 3.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 63.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.0¢ | 64824 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.635 |
3 | 139000 | 0.630 |
3 | 77617 | 0.625 |
6 | 178776 | 0.620 |
7 | 39673 | 0.615 |
Price($) | Vol. | No. |
---|---|---|
0.640 | 53478 | 2 |
0.645 | 15000 | 1 |
0.650 | 51500 | 2 |
0.655 | 41815 | 3 |
0.660 | 1280 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LRV (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online